Clinical Trial for Mesothelioma Patients: Antineoplaston Therapy
Read about a current clinical trial being conducted to study the effects of Antineoplaston therapy for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.
Rationale and Purpose: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. This phase II trial is studying how well antineoplaston therapy works in treating patients with advanced mesothelioma.
Requisite Condition: Malignant mesothelioma
Intervention: Drugs: antineoplaston A10; antineoplaston AS2-1. Procedures: antineoplastons therapy; differentiation therapy
Study Phase, Type and Description: Phase II Interventional treatment; Study of Antineoplastons A10 and AS2-1 in Patients with Mesothelioma
Courtesy of ClinicalTrials.gov.
Other helpful links:
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney